JSPRW Jasper Therapeutics, Inc. - Warrant
$0,02
Precio · May 19, 2026
Fundamentales a fecha de Mar 30, 2026
Rango 52S
$0–$0
35% of range
Calificación del Analista
—
Precio Objetivo
—
P/E (TTM)
—
ROE
-548.2%
Margen de Beneficio Neto
—
JSPRW Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.02
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$-3.95
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-548.2%
Deuda/Capital
—
Rango 52S
$0 – $0
JSPRW Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-3.95
2021-12-31
→
2025-12-31
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
ROA
-131.1%
—
ROE
-548.2%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Current Ratio (Ratio corriente)
2.6
—
Quick Ratio (Ratio Rápido)
2.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
JSPRW
Mediana de Pares
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | $42M | $34M | · | · | · | · | |
| R&D Expense | $63M | $56M | $52M | $35M | $25M | $16M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $11M | $5M | |
| Operating Expenses | $84M | $76M | $69M | $51M | $37M | $21M | |
| Operating Income | $-84M | $-76M | $-69M | $-51M | $-37M | $-21M | |
| Interest Income | $2M | $5M | $5M | $701.0K | · | · | |
| Other Non-op | $-2M | $-88.0K | $-246.0K | $586.0K | $-80.0K | · | |
| Pretax Income | · | · | · | · | · | $-6M | |
| Income Tax | · | $2.0K | $2.0K | · | · | · | |
| Net Income | $-76M | $-71M | $-64M | $-38M | $-31M | $-32M | |
| EPS (Basic) | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | · | |
| EPS (Diluted) | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 | · | |
| Shares (Basic) | 19,168,110 | 14,584,870 | 10,439,034 | 3,648,140 | 11,393,753 | · | |
| Shares (Diluted) | 19,168,110 | 14,584,870 | 10,439,034 | 3,648,140 | 11,393,753 | · | |
| EBITDA | $-84M | $-76M | $-68M | $-51M | $-37M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $72M | $87M | $38M | $85M | $20M | |
| Prepaid Expense | $6M | $4M | $2M | $3M | $3M | $247.0K | |
| Other Current Assets | $664.0K | $646.0K | $295.0K | $118.0K | $219.0K | · | |
| Current Assets | $35M | $76M | $89M | $42M | $88M | $21M | |
| PP&E (Net) | $102.0K | $2M | $3M | $4M | $4M | $693.0K | |
| PP&E (Gross) | $5M | $6M | $5M | $5M | $4M | $693.0K | |
| Accum. Depreciation | $5M | $4M | $2M | $1M | $377.0K | · | |
| Other Non-current Assets | $113.0K | $820.0K | $1M | $759.0K | $645.0K | $298.0K | |
| Total Assets | $36M | $80M | $95M | $48M | $94M | $23M | |
| Accounts Payable | $6M | $4M | $4M | $2M | $4M | $1M | |
| Accrued Liabilities | · | · | · | · | · | $925.0K | |
| Current Liabilities | $13M | $15M | $12M | $7M | $8M | $4M | |
| Capital Leases | · | $724.0K | $2M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $643.0K | $853.0K | |
| Total Liabilities | $32M | $18M | $16M | $12M | $24M | $15M | |
| Common Stock | $3.0K | $2.0K | $1.0K | · | $4.0K | $1.0K | |
| Paid-in Capital | $321M | $303M | $248M | $141M | $137M | $2M | |
| Retained Earnings | $-317M | $-241M | $-170M | $-105M | $-67M | $-37M | |
| Stockholders' Equity | $4M | $62M | $78M | $36M | $70M | $-35M | |
| Liabilities + Equity | $36M | $80M | $95M | $48M | $94M | $23M | |
| Shares Outstanding | 27,996,819 | 15,022,122 | 11,163,896 | 3,804,427 | 37,855,114 | 2,770,702 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $975.0K | $377.0K | · | |
| Stock-based Comp | $7M | $7M | $5M | $4M | $1M | $1M | |
| Other Non-cash | · | · | $6M | · | · | · | |
| Operating Cash Flow | $-77M | $-63M | $-52M | $-46M | $-34M | $-18M | |
| Investing Cash Flow | $5.0K | $-532.0K | $-267.0K | $-576.0K | $-2M | · | |
| Stock Issued | $6M | · | $101M | $28.0K | · | · | |
| Net Stock Activity | $6M | $47M | · | $28.0K | · | · | |
| Financing Cash Flow | $34M | $48M | $101M | $55.0K | $101M | $11M | |
| Net Change in Cash | · | · | · | · | · | $-442.6K |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | 27992.3% | · | 46041.2% | · | |
| Net Margin | · | · | 26205.3% | · | 38296.2% | · | |
| EBITDA Margin | · | · | 27541.9% | · | 46041.2% | · | |
| ROA | -131.1% | -81.5% | -90.0% | -53.1% | -52.4% | · | |
| ROE | -548.2% | -98.1% | -74.7% | -90.2% | -41.4% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 5.0 | 7.2 | 5.9 | 11.0 | · | |
| Quick Ratio | 2.2 | 4.7 | 7.0 | 5.4 | 10.6 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | -0.0 | · | -0.0 | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $-119.0K | $-119.0K | $-246.0K | $-115.0K | $-80.0K | $-111.0K | |
| Net Income TTM | $-76M | $-71M | $-64M | $-38M | $-31M | $-32M |
Estado de resultados 13
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $7M | $9M | · | · | $13M | $9M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $11M | $14M | $21M | $16M | $20M | $14M | $11M | $10M | $14M | $15M | $13M | $10M | $9M | $9M | $8M | $8M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | |
| Operating Expenses | $16M | $19M | $27M | $22M | $25M | $20M | $16M | $15M | $18M | $19M | $18M | $14M | $14M | $13M | $12M | $13M | |
| Operating Income | $-16M | $-19M | $-27M | $-22M | $-25M | $-20M | $-16M | $-15M | $-18M | $-19M | $-18M | $-14M | $-14M | $-13M | $-12M | $-13M | |
| Interest Income | $338.0K | $342.0K | $437.0K | $624.0K | $938.0K | $1M | $1M | $1M | $1M | $1M | $1M | · | $348.0K | $259.0K | · | · | |
| Other Non-op | $-29.0K | $-2M | $-84.0K | $-63.0K | $26.0K | $-32.0K | $-40.0K | $-42.0K | $-2M | $51.0K | $2M | $-313.0K | · | · | · | · | |
| Net Income | $-9M | $-19M | $-27M | $-21M | $-24M | $-19M | $-15M | $-14M | $-17M | $-18M | $-16M | $-14M | $-13M | $-12M | $-10M | $-2M | |
| EPS (Basic) | $0.33 | $-1.13 | $-1.74 | $-1.41 | $-1.65 | $-1.24 | $-0.97 | $-1.03 | $-1.49 | $-1.60 | $-1.47 | $-1.62 | $-9.66 | $-0.32 | $-0.29 | $-0.06 | |
| EPS (Diluted) | $0.33 | $-1.13 | $-1.74 | $-1.41 | $-1.65 | $-1.24 | $-0.97 | $-1.03 | $-1.49 | $-1.60 | $-1.47 | $-1.62 | $-9.66 | $-0.32 | $-0.29 | $-0.06 | |
| Shares (Basic) | -27,823,758 | 16,635,784 | 15,333,962 | 15,022,122 | -28,736,913 | 15,000,516 | 14,986,367 | 13,334,900 | -20,241,906 | 10,971,945 | 10,921,239 | 8,787,756 | -105,625,015 | 36,565,650 | 36,397,822 | 36,309,683 | |
| Shares (Diluted) | -27,823,758 | 16,635,784 | 15,333,962 | 15,022,122 | -28,736,913 | 15,000,516 | 14,986,367 | 13,334,900 | -20,241,906 | 10,971,945 | 10,921,239 | 8,787,756 | -105,625,015 | 36,565,650 | 36,397,822 | 36,309,683 | |
| EBITDA | · | $-19M | $-27M | $-22M | · | $-20M | $-16M | $-15M | · | $-19M | $-18M | $-14M | · | $-13M | $-12M | $-13M |
Balance general 21
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $51M | $40M | $49M | $72M | $93M | $107M | $118M | $87M | $104M | $116M | $129M | $38M | $51M | $61M | $70M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $3M | $3M | · | · | · | · | · | |
| Prepaid Expense | $6M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $2M | $1M | $3M | $3M | $3M | $1M | $2M | $3M | |
| Other Current Assets | $664.0K | $863.0K | $867.0K | $854.0K | $646.0K | $625.0K | $475.0K | $440.0K | $295.0K | · | $653.0K | $721.0K | $118.0K | $430.0K | $27.0K | $27.0K | |
| Current Assets | $35M | $55M | $43M | $53M | $76M | $95M | $109M | $120M | $89M | $105M | $119M | $133M | $42M | $52M | $63M | $74M | |
| PP&E (Net) | $102.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $811.0K | $593.0K | |
| Other Non-current Assets | $113.0K | $150.0K | $192.0K | $532.0K | $820.0K | $1M | $1M | $1M | $1M | $411.0K | $445.0K | $725.0K | $759.0K | $543.0K | $577.0K | $611.0K | |
| Total Assets | $36M | $57M | $46M | $58M | $80M | $99M | $114M | $126M | $95M | $110M | $124M | $139M | $48M | $59M | $70M | $81M | |
| Accounts Payable | $6M | $9M | $8M | $3M | $4M | $3M | $3M | $2M | $4M | $3M | $2M | $4M | $2M | $3M | $3M | $1M | |
| Current Liabilities | $13M | $21M | $20M | $12M | $15M | $12M | $10M | $9M | $12M | $12M | $9M | $8M | $7M | $7M | $7M | $6M | |
| Capital Leases | · | · | $201.0K | $755.0K | $724.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $707.0K | $749.0K | $641.0K | |
| Total Liabilities | $32M | $46M | $23M | $15M | $18M | $16M | $14M | $13M | $16M | $16M | $14M | $14M | $12M | $12M | $12M | $12M | |
| Common Stock | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $11.0K | $11.0K | $11.0K | · | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $321M | $319M | $312M | $304M | $303M | $300M | $298M | $297M | $248M | $247M | $246M | $245M | $141M | $139M | $139M | $138M | |
| Retained Earnings | $-317M | $-308M | $-289M | $-262M | $-241M | $-217M | $-198M | $-183M | $-170M | $-153M | $-135M | $-119M | $-105M | $-92M | $-80M | $-70M | |
| Stockholders' Equity | $4M | $12M | $24M | $42M | $62M | $84M | $100M | $113M | $78M | $94M | $110M | $125M | $36M | $48M | $59M | $68M | |
| Liabilities + Equity | $36M | $57M | $46M | $58M | $80M | $99M | $114M | $126M | $95M | $110M | $124M | $139M | $48M | $59M | $70M | $81M | |
| Shares Outstanding | 27,996,819 | 27,984,039 | 16,219,243 | 15,022,122 | 15,022,122 | 15,001,353 | 15,105,300 | 15,085,553 | 11,163,896 | 110,850,413 | 110,800,413 | 109,428,211 | 3,804,427 | 37,984,368 | 37,981,317 | 37,874,207 |
Flujo de Efectivo 7
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $290.0K | $229.0K | $258.0K | $279.0K | $285.0K | $500.0K | $300.0K | $288.0K | $234.0K | $300.0K | $300.0K | $274.0K | $273.0K | $300.0K | $218.0K | $216.0K | |
| Stock-based Comp | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $644.0K | $1M | $778.0K | |
| Operating Cash Flow | $-22M | $-17M | $-15M | $-23M | $-21M | $-14M | $-12M | $-16M | $-16M | $-12M | $-13M | $-10M | $-13M | $-10M | $-9M | $-14M | |
| Investing Cash Flow | $0 | $0 | $1.0K | $4.0K | $-76.0K | $-274.0K | $-157.0K | $-25.0K | $-230.0K | $0 | $-11.0K | $-26.0K | $-82.0K | $-222.0K | $-243.0K | $-29.0K | |
| Stock Issued | $0 | $514.0K | · | · | · | $0 | $0 | $47M | $0 | $0 | $0 | $101M | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | $47M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-340.0K | $28M | · | · | $345.0K | $9.0K | $181.0K | $47M | $-271.0K | $36.0K | $-305.0K | $102M | $28.0K | $1.0K | $13.0K | $13.0K |
Rentabilidad 5
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | -37964.7% | 16355.0% | 19924.3% | · | -4741.8% | -13441.6% | 17747.2% | |
| Net Margin | · | · | · | · | · | · | · | · | · | -34400.0% | 14752.3% | 20371.4% | · | -4426.5% | -11689.9% | 3065.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | -37376.5% | 16355.0% | 19924.3% | · | -4741.8% | -13441.6% | 17747.2% | |
| ROA | · | -23.9% | -33.3% | -23.1% | · | -17.8% | -12.2% | -10.4% | · | -20.7% | -16.5% | -13.0% | · | -14.3% | -12.2% | -2.4% | |
| ROE | · | -39.3% | -43.2% | -27.3% | · | -21.0% | -13.9% | -11.5% | · | -24.8% | -19.0% | -14.8% | · | -18.8% | -32.6% | -6.0% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | 2.1 | 4.3 | · | 7.6 | 10.8 | 13.5 | · | 8.8 | 13.2 | 16.8 | · | 7.1 | 9.6 | 12.4 | |
| Quick Ratio | · | 2.4 | 1.9 | 4.0 | · | 7.4 | 10.6 | 13.3 | · | 9.0 | 13.3 | 16.4 | · | 6.9 | 9.2 | 11.8 |
Eficiencia 1
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | 0.0 | -0.0 | -0.0 | · | 0.0 | 0.0 | -0.0 |
Valoración (TTM) 2
| Métrica | Tendencia | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | $-173.0K | $-138.0K | · | $-77.0K | $-82.0K | $-78.0K | |
| Net Income TTM | · | $-85M | $-81M | $-68M | · | $-64M | $-62M | $-62M | · | $-60M | $-53M | $-39M | · | $-28M | $-24M | $-24M |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | — | — | 27992.3% | — | 46041.2% |
| Beneficio neto | $-76M | $-71M | $-64M | $-38M | $-31M |
| EPS Diluido | $-3.95 | $-4.89 | $-6.18 | $-10.33 | $-2.69 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.6 | 5.0 | 7.2 | 5.9 | 11.0 |
| Ratio Rápido | 2.2 | 4.7 | 7.0 | 5.4 | 10.6 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.